Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning to Predict Outcomes of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration.

Ophthalmology science·2026
Same author

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK).

BMJ (Clinical research ed.)·2026
Same author

Code-free automated machine learning for OCT-based classification of vitreoretinal interface diseases.

International journal of retina and vitreous·2026
Same author

Central and Peripheral Alterations of Retinal and Choroidal Vasculature in Multiple Sclerosis: Insights from Multimodal Imaging.

Ophthalmology science·2026
Same author

Residents versus experts in interpreting standard Scheimpflug imaging for the diagnosis of keratoconus.

European journal of ophthalmology·2026

Related Experiment Video

Updated: Feb 28, 2026

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.2K

Tomographic Biomarkers Differ by Progression Risk to Late Macular Degeneration.

Enrico Bernardi1, Usha Chakravarthy2, Katherine A Muldrew2

  • 1Department of Ophthalmology, Belfast Health and Social Care Trust, Belfast, United Kingdom; Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Ophthalmology. Retina
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

The study found that the progression of Age-related Macular Degeneration (AMD) differs between High-Risk Features (HRF) and Subretinal Drusen Deposits (SDD). HRF elevates the risk of developing geographic atrophy (FoA), with or without neovascular AMD (nAMD), while SDD only progresses to FoA, indicating unique disease pathways.

Keywords:
Age-related macular degenerationFocal atrophyHyperreflective fociNeovascular AMDSubretinal drusenoid deposits

More Related Videos

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.3K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K

Related Experiment Videos

Last Updated: Feb 28, 2026

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.2K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.3K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K

Area of Science:

  • Ophthalmology
  • Genetics
  • Cell Biology

Background:

  • Age-related Macular Degeneration (AMD) is a leading cause of vision loss.
  • Distinct phenotypes of AMD suggest underlying differences in disease mechanisms.
  • Understanding progression pathways is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the differential progression of AMD based on specific features.
  • To compare the impact of High-Risk Features (HRF) versus Subretinal Drusen Deposits (SDD) on AMD progression.
  • To elucidate distinct biological pathways driving AMD outcomes.

Main Methods:

  • Retrospective analysis of longitudinal AMD patient data.
  • Categorization of AMD progression based on established phenotypes.
  • Statistical comparison of progression rates between HRF and SDD groups.

Main Results:

  • High-Risk Features (HRF) significantly increased the risk of progression to geographic atrophy (FoA), with or without co-occurring neovascular AMD (nAMD).
  • Subretinal Drusen Deposits (SDD) were associated with progression solely to FoA.
  • The observed differences suggest divergent pathophysiological mechanisms.

Conclusions:

  • HRF and SDD represent distinct risk factors for AMD progression.
  • The pathways leading to FoA differ depending on the initial feature (HRF vs. SDD).
  • These findings highlight the need for phenotype-specific management strategies in AMD.